Pfizer scraps daily weight loss pill after liver injury in one patient

Thread starter U.S. News
Start date Apr 14, 2025

U.S. News

Guest

Apr 14, 2025

The decision to stop developing danuglipron adds to a string of setbacks in the pharmaceutical giant's bid to win a slice of the booming market for GLP-1s.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: Pfizer scraps daily weight loss pill after liver injury in one patient

Prefix: N/A

Forum: USA News

Start date: Apr 14, 2025

Last reply date: Apr 14, 2025

Replies: 0

Thread Tags

Thread statistics

Created: U.S. News, Apr 14, 2025

Replies: 0

Views: 15

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search